| View |
|
DR-XY48033
|
Sevoflurane
|
Sevoflex
|
100% v/v
|
Liquid for Inhalation
|
General Anesthetic
|
Shanghai Hengrui Pharmaceutical Co., Ltd.
|
China
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DR-XY48034
|
Metronidazole
|
Polgyl
|
5 mg/ mL (500 mg/ 100 mL)
|
Solution for I.V. Infusion
|
Antibacterial /Antiprotozoal (Nitroimidazole Derivative)
|
Polifarma Ilac San. Ve Tic A.S.
|
Turkey
|
Initial
|
20 May 2022
|
20 May 2027
|
| View |
|
DR-XY48035
|
Ascorbic Acid + Zinc
|
None
|
500mg (equivalent to 605.327mg Calcium Ascorbate) / 10mg (equivalent to 75.93 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
Northfield Laboratories Inc.
|
Philippines
|
Initial (OTC)
|
23 May 2022
|
23 May 2027
|
| View |
|
DR-XY48039
|
Telmisartan + Hydrochlorothiazide
|
Telmi HCT
|
80 mg/12.5 mg
|
Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Ajanta Pharma Limited
|
India
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DR-XY48041
|
Paricalcitol
|
Parical
|
2 mcg/mL
|
Solution for Injection (IV)
|
Other Anti-Parathyroid Agents
|
Pharmathen SA
|
Greece
|
Monitored Release
|
25 May 2022
|
25 May 2027
|
| View |
|
DR-XY48042
|
Paricalcitol
|
Parical
|
5 mcg/mL
|
Solution for Injection (IV)
|
Other Anti-Parathyroid Agents
|
Pharmathen SA
|
Greece
|
Monitored Release
|
25 May 2022
|
25 May 2027
|
| View |
|
DR-XY48043
|
Esmolol hydrochloride
|
Esmo-IV
|
10 mg/mL
|
Solution for Injection (IV)
|
Beta Adrenoceptor Blocker
|
Myungmoon Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DR-XY48044
|
Etoricoxib
|
Arthrimed 60
|
60 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/Antirheumatic
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DR-XY48045
|
Etoricoxib
|
Arthrimed 90
|
90 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/Antirheumatic
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial
|
25 May 2022
|
25 May 2027
|
| View |
|
DR-XY48046
|
Etoricoxib
|
Arthrimed 120
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/Antirheumatic
|
Unison Laboratories Co., Ltd.
|
Thailand
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DR-XY48047
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3)
|
Vitammune
|
500 mg (Equivalent to 562.43 mg Sodium Ascorbate)/10mg
(Equivalent to 70 mg Zinc Gluconate )/1000 IU
|
Capsule
|
Vitamin/ Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
31 May 2022
|
31 May 2027
|
| View |
|
DR-XY48048
|
Ascorbic Acid + Zinc + Colecalciferol (Vitamin D3)
|
Doctri-Cee Max
|
533.40mg (equivalent to 600mg Sodium Ascorbate) /
5 mg (equivalent to 13.725mg Zinc Sulfate Monohydrate)
/ 1000 IU
|
Capsule
|
Vitamin / Mineral
|
Theramedic Laboratories Corp.
|
Philippines
|
Initial (OTC)
|
31 May 2022
|
31 May 2027
|
| View |
|
DR-XY48049
|
Ascorbic Acid + Zinc
|
Doctri-Cee Plus
|
533.40mg (equivalent to 600mg Sodium Ascorbate) /
10mg (equivalent to 27.45mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin / Mineral
|
Theramedic Laboratories Corp.
|
Philippines
|
Initial
|
01 June 2022
|
01 June 2027
|
| View |
|
DR-XY48050
|
Lenalidomide
|
Lenangio 25
|
25 mg
|
Capsule
|
-
|
Dr. Reddy's Laboratories Ltd. (Formulation Technical
Operations Unit-VII)
|
India
|
Monitored Release
|
26 May 2022
|
26 May 2025
|
| View |
|
DR-XY48051
|
Lenalidomide
|
Lenangio 15
|
15 mg
|
Capsule
|
-
|
Dr. Reddy's Laboratories Ltd. (Formulation Technical
Operations Unit-VII)
|
India
|
Monitored Release
|
26 May 2022
|
26 May 2025
|
| View |
|
DR-XY48052
|
Lenalidomide
|
Lenangio 10
|
10 mg
|
Capsule
|
Immunosuppressant
|
Dr. Reddy's Laboratories Ltd. (Formulation Technical
Operations Unit-VII)
|
India
|
Monitored Release
|
26 May 2022
|
26 May 2025
|
| View |
|
DR-XY48053
|
Lenalidomide
|
Lenangio 5
|
5 mg
|
Capsule
|
Immunosuppressant
|
Dr. Reddy's Laboratories Ltd. (Formulation Technical
Operations Unit-VII)
|
India
|
Monitored Release
|
26 May 2022
|
26 May 2025
|
| View |
|
DR-XY48054
|
Lidocaine Hydrochloride
|
Lignovell
|
20 mg/mL (2% w/v)
|
Solution for Injection (IV)
|
Local Anaesthetic
|
Pt. Novell Pharmaceutical Laboratories
|
Indonesia
|
Initial (Correction)
|
23 June 2022
|
26 May 2027
|
| View |
|
DR-XY48055
|
Doxofylline
|
Dilatair
|
200 mg
|
Tablet
|
Bronchodilator
|
Ajanta Pharma Limited
|
India
|
Initial
|
26 May 2022
|
26 May 2027
|
| View |
|
DR-XY48056
|
Phenylephrine (as hydrochloride)
|
Phenylalpha
|
50 mcg/mL (500 mcg/10 mL)
|
Solution for I.V. Injection
|
Adrenergic/Dopaminergic Agent
|
Laboratoire Aguettant
|
France
|
Initial
|
27 May 2022
|
27 May 2027
|